Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genome- |
RCV001578661 | SCV001805924 | uncertain significance | Peroxisome biogenesis disorder 9B | 2021-07-14 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001578662 | SCV001805925 | uncertain significance | Rhizomelic chondrodysplasia punctata type 1 | 2021-07-14 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002368604 | SCV002623912 | uncertain significance | Inborn genetic diseases | 2022-08-30 | criteria provided, single submitter | clinical testing | The p.R13Q variant (also known as c.38G>A), located in coding exon 1 of the PEX7 gene, results from a G to A substitution at nucleotide position 38. The arginine at codon 13 is replaced by glutamine, an amino acid with highly similar properties. This amino acid position is conserved. In addition, the in silico prediction for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |